No profile data available.
Impact BioMedical Inc. (IBO) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Houston, United States, with about 2 full-time employees.
It reported revenue of $32,000 for fiscal year 2025, and net income of -$11.84 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $3,000, down 57.1% from a year before. Its market capitalization was $49.17 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
Impact BioMedical reported $32,000 in revenue for fiscal year 2025. In Q2 2026 revenue was $3,000.
$49.17 million as of December 4, 2025.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Metagenomi, Inc. (MGX), Eloxx Pharmaceuticals, Inc. (ELOX), MiNK Therapeutics, Inc. (INKT), Telomir Pharmaceuticals, Inc. (TELO).